BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36263173)

  • 21. MUC1-C activates EZH2 expression and function in human cancer cells.
    Rajabi H; Hiraki M; Tagde A; Alam M; Bouillez A; Christensen CL; Samur M; Wong KK; Kufe D
    Sci Rep; 2017 Aug; 7(1):7481. PubMed ID: 28785086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis.
    Cao X; He W; Rong K; Xu S; Chen Z; Liang Y; Han S; Zhou Y; Yang X; Ma H; Qin A; Zhao J
    Stem Cell Res Ther; 2021 Dec; 12(1):605. PubMed ID: 34930462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.
    Kochat V; Equbal Z; Baligar P; Kumar V; Srivastava M; Mukhopadhyay A
    PLoS One; 2017; 12(3):e0173977. PubMed ID: 28328977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention.
    Tellez CS; Picchi MA; Juri D; Do K; Desai DH; Amin SG; Hutt JA; Filipczak PT; Belinsky SA
    Clin Epigenetics; 2021 Feb; 13(1):44. PubMed ID: 33632299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression.
    Bhattacharya A; Fushimi A; Wang K; Yamashita N; Morimoto Y; Ishikawa S; Daimon T; Liu T; Liu S; Long MD; Kufe D
    Commun Biol; 2023 Oct; 6(1):1030. PubMed ID: 37821650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of p53 and Rb links the alternative NF-κB pathway to EZH2 expression and cell senescence.
    Iannetti A; Ledoux AC; Tudhope SJ; Sellier H; Zhao B; Mowla S; Moore A; Hummerich H; Gewurz BE; Cockell SJ; Jat PS; Willmore E; Perkins ND
    PLoS Genet; 2014 Sep; 10(9):e1004642. PubMed ID: 25255445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors.
    Huang X; Yan J; Zhang M; Wang Y; Chen Y; Fu X; Wei R; Zheng XL; Liu Z; Zhang X; Yang H; Hao B; Shen YY; Su Y; Cong X; Huang M; Tan M; Ding J; Geng M
    Cell; 2018 Sep; 175(1):186-199.e19. PubMed ID: 30220457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3.
    Wiese M; Schill F; Sturm D; Pfister S; Hulleman E; Johnsen SA; Kramm CM
    Klin Padiatr; 2016 Apr; 228(3):113-7. PubMed ID: 27135271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.
    Yamagishi M; Hori M; Fujikawa D; Ohsugi T; Honma D; Adachi N; Katano H; Hishima T; Kobayashi S; Nakano K; Nakashima M; Iwanaga M; Utsunomiya A; Tanaka Y; Okada S; Tsukasaki K; Tobinai K; Araki K; Watanabe T; Uchimaru K
    Cell Rep; 2019 Nov; 29(8):2321-2337.e7. PubMed ID: 31747604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycomb-dependent epigenetic landscape in adult T-cell leukemia.
    Fujikawa D; Nakagawa S; Hori M; Kurokawa N; Soejima A; Nakano K; Yamochi T; Nakashima M; Kobayashi S; Tanaka Y; Iwanaga M; Utsunomiya A; Uchimaru K; Yamagishi M; Watanabe T
    Blood; 2016 Apr; 127(14):1790-802. PubMed ID: 26773042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2.
    Song Z; Wu W; Chen M; Cheng W; Yu J; Fang J; Xu L; Yasunaga JI; Matsuoka M; Zhao T
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic suppression of iNOS expression in human endothelial cells: A potential role of Ezh2-mediated H3K27me3.
    Dreger H; Ludwig A; Weller A; Baumann G; Stangl V; Stangl K
    Genomics; 2016 Apr; 107(4):145-9. PubMed ID: 26853880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis.
    Liu J; Zhan Y; Wang J; Wang J; Guo J; Kong D
    Mol Oncol; 2020 Dec; 14(12):3211-3233. PubMed ID: 33040438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
    Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
    FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
    Yu Y; Qi J; Xiong J; Jiang L; Cui D; He J; Chen P; Li L; Wu C; Ma T; Shao S; Wang J; Yu D; Zhou B; Huang D; Schmitt CA; Tao R
    Theranostics; 2019; 9(3):761-777. PubMed ID: 30809307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
    Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57
    Qiao E; Chen D; Li Q; Feng W; Yu X; Zhang X; Xia L; Jin J; Yang H
    J Cell Biochem; 2019 Mar; 120(3):3978-3988. PubMed ID: 30378143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains.
    Donaldson-Collier MC; Sungalee S; Zufferey M; Tavernari D; Katanayeva N; Battistello E; Mina M; Douglass KM; Rey T; Raynaud F; Manley S; Ciriello G; Oricchio E
    Nat Genet; 2019 Mar; 51(3):517-528. PubMed ID: 30692681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.